Associate Professor, Radiation Oncology, Medical College of Wisconsin
Radiation Oncology
Dr. Elizabeth Gore, MD
|
|
Give Review
Elizabeth Gore, MD is an expert in the field of Radiation Oncology. He attended Medical College of Wisconsin. Medical College of Wisconsin has a rank of 54 in research and a 62 in primary care He received 2 awards: "Regional Top Doctor" and "Super Doctor". Dr. Elizabeth Gore has written publications. He has 42 publications published with PubMed. The lastest paper is: 'Pulmonary function changes in long-term survivors of bone marrow transplantation.'
Publications
- Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08.
- Cisplatin and Etoposide Versus Carboplatin and Paclitaxel With Concurrent Radiotherapy for Stage III Non-Small-Cell Lung Cancer: An Analysis of Veterans Health Adminis...
- Determination of Internal Target Volume for Radiation Treatment Planning of Esophageal Cancer by Using 4-Dimensional Computed Tomography (4DCT).
- ACR Appropriateness Criteria(®) Pre-Irradiation Evaluation and Management of Brain Metastases.
- Decline in Tested and Self-Reported Cognitive Functioning After Prophylactic Cranial Irradiation for Lung Cancer: Pooled Secondary Analysis of Radiation Therapy Oncolo...
- Symptomatic Radiation Pneumonitis in Elderly Patients Receiving Thoracic Irradiation.
- Evaluation and management of elderly patients with lung cancer.
- Decreased risk of radiation pneumonitis with incidental concurrent use of Angiotensin-converting enzyme inhibitors and thoracic radiation therapy.
- TH-E-218-09: Extracting Patient-Specific Radiobiological Parameters for Radiobiologically Adaptive Radiotherapy Based on Radiation Response for Lung Cancer.
- Muscle endurance, cancer-related fatigue, and radiotherapy in prostate cancer survivors.
- Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation...
- Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-...
- Higher Biologically Effective Dose of Radiotherapy is Associated with Improved Outcomes for Locally Advanced Non-Small Cell Lung Carcinoma Treated with Chemoradiation:...
- Limited-stage small cell lung cancer: current chemoradiotherapy treatment paradigms.
- Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer: an ASTRO outcomes initiative.
- Feasibility of neurocognitive outcome evaluations in patients with brain metastases in a multi-institutional cooperative group setting: results of Radiation Therapy On...
- Prophylactic cranial irradiation for patients with locally advanced non-small-cell lung cancer.
- Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis.
- A controlled time-series trial of clinical reminders: using computerized firm systems to make quality improvement research a routine part of mainstream practice.
- Tracheoesophageal fistula associated with bevacizumab 21 months after completion of radiation therapy.
- Do "elderly fit" patients have less comorbidity?
- Comparison of high dose-rate and low dose-rate dose distributions for vaginal cylinders.
- Gated treatment delivery verification with on-line megavoltage fluoroscopy.
- RTOG 0214: a phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small cell lung cancer.
- Prophylactic cranial irradiation versus observation in stage III non-small-cell lung cancer.
- Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410.
- Age is independent of comorbidity influencing patient selection for combined modality therapy for treatment of stage III nonsmall cell lung cancer (NSCLC).
- Posttreatment visual acuity in patients treated with episcleral plaque therapy for choroidal melanomas: dose and dose rate effects.
- Stereotactic body radiation therapy for inoperable early stage lung cancer.
- Celecoxib and radiation therapy in non-small-cell lung cancer.
- Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinom...
- The effects of comorbidity and age on RTOG study enrollment in Stage III non-small cell lung cancer patients who are eligible for RTOG studies.
- A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of R...
- Non-small cell lung cancer and central nervous system metastases: should we be using prophylactic cranial irradiation?
- Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated o...
- Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer.
- Phase I/II trial of a COX-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung cancer: radiation ...
- Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy f...
- Pulmonary function changes in long-term survivors of bone marrow transplantation.
- Brain metastases in very young patients with lung cancer are still brain metastases.
- Non-surgical management of stage I lung cancer.
Schools
Medical College of Wisconsin
Med College Of Wisconsin
Doctors Specialties
- Radiation Oncology
Accepted Insurances
- Choice Plus POS II
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Preferred Plus POS
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- First Health (Coventry Health Care) PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- Regional Top Doctor
- Super Doctor
Education
-
Medical College of Wisconsin Affiliated Hospitals -
Medical College of Wisconsin
Hospital
-
Children's Hospital of Wisconsin -
Froedtert Memorial Lutheran Hospital
Drug Facts
| NPI NUMBER | 1710938519 | |
| NPPES Provider LastName | GORE | |
| NPPES Provider FirstName | ELIZABETH | |
| NPPES Provider ZIPCode | 532263522 | |
| NPPES Provider State | WI | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 25.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1710938519 |
| Last Name Of The Provider | GORE |
| First Name Of The Provider | ELIZABETH |
| View All |
Similar Doctors
|
John M. Longo |
|
|
Dr. Beth Erickson, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Adam Currey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ellen L. Ziaja, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric A. Mellon, MD |
|
Dr. Selim Y. Firat, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carmen R. Bergom, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth M. Gore, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Irina V. Sparks, MD |
|
|
Dr. Michael W. Straza, MD |